Literature DB >> 11339380

Evolutionarily conserved low copy repeats (LCRs) in 22q11 mediate deletions, duplications, translocations, and genomic instability: an update and literature review.

T H Shaikh1, H Kurahashi, B S Emanuel.   

Abstract

Several constitutional rearrangements, including deletions, duplications, and translocations, are associated with 22q11.2. These rearrangements give rise to a variety of genomic disorders, including DiGeorge, velocardiofacial, and conotruncal anomaly face syndromes (DGS/VCFS/CAFS), cat eye syndrome (CES), and the supernumerary der(22)t(11;22) syndrome associated with the recurrent t(11;22). Chromosome 22-specific duplications or low copy repeats (LCRs) have been directly implicated in the chromosomal rearrangements associated with 22q11.2. Extensive sequence analysis of the different copies of 22q11 LCRs suggests a complex organization. Examination of their evolutionary origin suggests that the duplications in 22q11.2 may predate the divergence of New World monkeys 40 million years ago. Based on the current data, a number of models are proposed to explain the LCR-mediated constitutional rearrangements of 22q11.2.

Entities:  

Mesh:

Year:  2001        PMID: 11339380     DOI: 10.1097/00125817-200101000-00003

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  45 in total

1.  A palindrome-mediated mechanism distinguishes translocations involving LCR-B of chromosome 22q11.2.

Authors:  Anthony L Gotter; Tamim H Shaikh; Marcia L Budarf; C Harker Rhodes; Beverly S Emanuel
Journal:  Hum Mol Genet       Date:  2003-11-12       Impact factor: 6.150

2.  22q11.2 Microduplications: Two Clinical Reports Compared with Similar Cases from the Literature.

Authors:  Aderonke Oyetunji; Merlin G Butler
Journal:  J Pediatr Genet       Date:  2020-01-10

3.  Evidence for widespread reticulate evolution within human duplicons.

Authors:  Michael S Jackson; Karen Oliver; Jane Loveland; Sean Humphray; Ian Dunham; Mariano Rocchi; Luigi Viggiano; Jonathan P Park; Matthew E Hurles; Mauro Santibanez-Koref
Journal:  Am J Hum Genet       Date:  2005-09-30       Impact factor: 11.025

Review 4.  Orofacial clefting: recent insights into a complex trait.

Authors:  Astanand Jugessur; Jeffrey C Murray
Journal:  Curr Opin Genet Dev       Date:  2005-06       Impact factor: 5.578

5.  MLPA: a rapid, reliable, and sensitive method for detection and analysis of abnormalities of 22q.

Authors:  J A S Vorstman; G R Jalali; E F Rappaport; A M Hacker; C Scott; B S Emanuel
Journal:  Hum Mutat       Date:  2006-08       Impact factor: 4.878

6.  A palindrome-driven complex rearrangement of 22q11.2 and 8q24.1 elucidated using novel technologies.

Authors:  Anthony L Gotter; Manjunath A Nimmakayalu; G Reza Jalali; April M Hacker; Jacob Vorstman; Danielle Conforto Duffy; Livija Medne; Beverly S Emanuel
Journal:  Genome Res       Date:  2007-03-09       Impact factor: 9.043

7.  Congenital anomalies and rhabdoid tumor associated with 22q11 germline deletion and somatic inactivation of the SMARCB1 tumor suppressor.

Authors:  George Toth; Claudia B Zraly; Tricia L Thomson; Carolyn Jones; Shawn Lapetino; Jonathan Muraskas; Jiwang Zhang; Andrew K Dingwall
Journal:  Genes Chromosomes Cancer       Date:  2011-03-15       Impact factor: 5.006

8.  Signature MicroRNA expression patterns identified in humans with 22q11.2 deletion/DiGeorge syndrome.

Authors:  M Teresa de la Morena; Jennifer L Eitson; Igor M Dozmorov; Serkan Belkaya; Ashley R Hoover; Esperanza Anguiano; M Virginia Pascual; Nicolai S C van Oers
Journal:  Clin Immunol       Date:  2013-01-30       Impact factor: 3.969

Review 9.  22q11 deletion syndrome: a role for TBX1 in pharyngeal and cardiovascular development.

Authors:  Peter J Scambler
Journal:  Pediatr Cardiol       Date:  2010-04       Impact factor: 1.655

10.  Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome.

Authors:  Anne S Bassett; Christian R Marshall; Anath C Lionel; Eva W C Chow; Stephen W Scherer
Journal:  Hum Mol Genet       Date:  2008-09-20       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.